We show that the percentage of GM-CSF-expressing stimulated peripheral blood mononuclear cells (PBMC) subsets (Th cells, Tc cells, monocytes, natural killer (NK) cells, and B cells) is higher in MS patients when compared to healthy controls (HCs). The gene discussed is CSF2; the disease is myeloid sarcoma.